. 2022 Jun 10;13:918899. doi: 10.3389/fendo.2022.918899

Table 3.

OTC/OTT Participant characteristics for fertility and hormone outcomes (21, 22, 25, 34, 37, 44, 57, 59, 61, 64, 66, 78, 84, 91–93, 95, 111, 115, 118, 124).

Size of processed ovarian tissue	Strips	Squares	Fragments
Range Dimensions of processed ovarian tissue Length x Width (mm² )	6-10 x 2-5	5 x 5	2-3 x 1-2
Most common dimension Length x Width (mm² ), (n=67)	6 x 4 (n = 28)	5 x 5 (n = 37)	2 x 2 (n = 2)
No. of OTC/OTT participants	51	37	4
Method of cryopreservation (Slow freeze, Vitrification)	Slow freeze: 50 Vitrification: 0	Slow freeze: 37 Vitrification: 0	Slow freeze: 4 Vitrification: 0
Mean Age at OTC Years ± SD, Range	27.4 ± 6.6, 9-40	29.8 ± 5.31, 15.4-38	22.8 ± 3.3, 18-25
Mean Age at OTT Years ± SD, Range	33.1 ± 5.3, 13.6-41.9	33.8± 4.95, 27-43	30.3 ± 1.7, 28-32
No. of participants with previous treatment prior to OTC	21	2	1
Average number of tissues transplanted, ± SD, Range (1^st, 2^nd, 3^rd)	1^st: 11.5 ± 7.8, 2-46 2^nd: 11.7 ± 4, 8-16 (n=7)	1^st:10.9 ± 2.8, 6-17 2^nd: 8.3 ± 4.3, 3-16 (n=10)	1^st: 21.8 ± 30.3, 4-67 2^nd: 20 (n=1) 3^rd: 49 (n=1)
Av. Area of tissue transplanted (mm²) ± SD, Range, mm² (Total, 1^st, 2^nd, 3^rd)	Total: 394.58 ± 262.7, 40 – 1152 1^st: 334.0 ± 172.5, 40-920 2^nd: 385.75 ± 100.7, 216-550 3^rd: -	Total: 328.4 ± 128, 150 -750 1^st; 271.8 ± 69.9, 150-425 2^nd: 207.5 ± 108, 75-400 mm² 3^rd: -	Total: 134.8 ± 139.8, 12-268 1^st; 83 ± 123.8, 12-268 2^nd: 60 (n=1) 3^rd:147 (n=1)